Obfuscation of the activity of antifungal antimicrobics by culture media.

PubWeight™: 7.47‹?› | Rank: Top 0.1%

🔗 View Article (PMID 4561725)

Published in J Infect Dis on October 01, 1972

Authors

P D Hoeprich, P D Finn

Articles citing this

Antifungal susceptibility testing. Clin Microbiol Rev (1993) 9.04

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother (1976) 8.54

Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods. Antimicrob Agents Chemother (1978) 5.94

Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol (1986) 5.19

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother (1986) 4.97

Antifungal susceptibility tests. Antimicrob Agents Chemother (1987) 4.76

In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy. Antimicrob Agents Chemother (1989) 4.00

Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media. Antimicrob Agents Chemother (1984) 3.74

Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. J Clin Microbiol (1986) 3.40

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother (1986) 3.38

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother (1991) 2.81

Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev (1973) 2.58

Problems in the laboratory assessment of antifungal activity. Postgrad Med J (1979) 2.43

Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother (2004) 2.28

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrob Agents Chemother (1982) 2.28

Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother (1997) 2.07

Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob Agents Chemother (1989) 1.89

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother (1988) 1.85

Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis. Antimicrob Agents Chemother (1990) 1.81

Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother (1989) 1.78

Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev (1973) 1.76

Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. Antimicrob Agents Chemother (1991) 1.72

Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol (2001) 1.68

pH and other effects on the antifungal activity of cilofungin (LY121019). Antimicrob Agents Chemother (1989) 1.60

Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrob Agents Chemother (1989) 1.53

Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion. Antimicrob Agents Chemother (1992) 1.52

Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis. Antimicrob Agents Chemother (1992) 1.50

Tablet sensitivity testing on pathogenic fungi. J Clin Pathol (1979) 1.45

In vitro and in vivo antifungal activities of D0870, a new triazole agent. Antimicrob Agents Chemother (1993) 1.44

Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44

Susceptibility differences of inbred strains of mice to blastomycosis. Infect Immun (1981) 1.37

Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35

Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect Immun (1981) 1.25

Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use. Antimicrob Agents Chemother (1984) 1.21

In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother (1995) 1.12

Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent. Antimicrob Agents Chemother (1990) 1.11

Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun (2004) 1.00

Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother (2006) 0.93

Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth. Antimicrob Agents Chemother (1989) 0.93

Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B. Antimicrob Agents Chemother (1977) 0.92

Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates. Infect Immun (1991) 0.91

Fungicidal mechanism of action of D0870 against Cryptococcus neoformans under acidic conditions. Antimicrob Agents Chemother (1997) 0.88

Antifungal and antibacterial activities of diarylamidine derivatives. Antimicrob Agents Chemother (1980) 0.88

Progesterone binding and inhibition of growth in Trichophyton mentagrophytes. Infect Immun (1986) 0.87

Dermatophyte-hormone relationships: characterization of progesterone-binding specificity and growth inhibition in the genera Trichophyton and Microsporum. J Clin Microbiol (1988) 0.84

Specific induction of fibronectin binding activity by hemoglobin in Candida albicans grown in defined media. Infect Immun (1996) 0.83

Fungal peritonitis caused by Lecythophora mutabilis. J Clin Microbiol (1985) 0.82

Effect of ketoconazole in combination with other inhibitors of sterol synthesis on fungal growth. Antimicrob Agents Chemother (1985) 0.81

Chemically defined medium for susceptibility testing of antimicrobial agents. Antimicrob Agents Chemother (1976) 0.79

In vitro susceptibility of Prototheca spp. to gentamicin. Antimicrob Agents Chemother (1991) 0.78

Effects of agars on determination of potency of polymyxin B sulfate by the agar plate diffusion method. Antimicrob Agents Chemother (1994) 0.75

Phaeohyphomycotic cyst caused by a recently described species, Phaeoannellomyces elegans. J Clin Microbiol (1987) 0.75

Infectious diseases: annual review of significant publications. Postgrad Med J (1973) 0.75

Articles by these authors

Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60

Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40

Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43

Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31

Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23

Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09

Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83

Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81

Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74

Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57

Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55

Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52

Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50

Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44

Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39

Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38

Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36

Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36

Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35

Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32

Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31

Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30

An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27

Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23

Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20

Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20

Observations and comments concerning the isolation of group B beta-hemolytic streptococci from human sources. Can Med Assoc J (1970) 1.18

Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18

Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17

Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17

Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16

Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15

Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10

Treatment of open fractures: a prospective study. J Trauma (1983) 1.10

Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08

Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05

Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05

Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03

Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03

The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02

Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01

Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00

Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med (1967) 0.99

Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry (1983) 0.98

Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med (1981) 0.98

The polymyxins. Med Clin North Am (1970) 0.97

Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.94

In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94

Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94

Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature (1971) 0.94

Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93

Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91

Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91

Providence bacillus bacteremia and septicopyemia. Am J Med (1968) 0.91

Purification of High Titer Tetanus Toxin. J Bacteriol (1945) 0.90

Reproducible method for induction of pulmonary coccidioidomycosis in mice. J Infect Dis (1977) 0.90

Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis (1992) 0.88

In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 0.88

Parenteral sodium ampicillin therapy of endocarditis, salmonellosis, and other bacterial infections. Antimicrob Agents Chemother (Bethesda) (1965) 0.88

Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch Intern Med (1975) 0.88

Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med (1971) 0.88

Shigellemia. West J Med (1984) 0.87

Reliability of a commercial triphenyltetrazolium chloride reduction test for detecting significant bacteriuria. Am J Med Sci (1966) 0.87

Entry of four cephalosporins into the ovine lung. J Infect Dis (1984) 0.87

Etiologic diagnosis of lower respiratory tract infections. Calif Med (1970) 0.86

Cold sterilization of ureteral catheters with ethylene oxide gas. J Urol (1966) 0.86

Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc Natl Acad Sci U S A (1991) 0.85

Entry of four tetracyclines into saliva and tears. Antimicrob Agents Chemother (1974) 0.85

Toxicity of amphotericins on chronic administration to mongrel dogs. Diagn Microbiol Infect Dis (1985) 0.84

In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Antimicrob Agents Chemother (1973) 0.84

The penicillins, old and new. Review and perspectives. Calif Med (1968) 0.83

New antifungal drugs in the therapy of systemic mycoses. Scand J Infect Dis Suppl (1978) 0.82

Analysis of bacterial isolates from cerebrospinal fluid. J Clin Microbiol (1984) 0.81

A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. J Biol Chem (1985) 0.81

Engulfment and bactericidal capabilities of peripheral blood leukocytes in chronic leukemias. Cancer (1969) 0.81

Influence of culture media on the antistaphylococcal activity of fosfomycin. Appl Microbiol (1971) 0.80

Quantitative microbiology of traumatic orthopedic wounds. J Clin Microbiol (1978) 0.80

The effects of anesthetic agents on murine pulmonary bactericidal activity. Anesthesiology (1971) 0.80

Diagnostic value of gallium and bone scans in evaluation of extrapulmonary coccidioidal lesions. Am Rev Respir Dis (1980) 0.79

Typhoid fever caused by chloramphenicol-resistant organisms. JAMA (1973) 0.79

Cellular receptors to the anaphylatoxins C3a and C5a. Biochem Soc Symp (1986) 0.79

Sexually dimorphic cell groups in the medial preoptic area that are essential for male sex behavior and the neural pathways needed for their effects. Psychoneuroendocrinology (1994) 0.79

Antifungal chemotherapy. Prog Drug Res (1995) 0.78

New antimicrobics for the treatment of infections caused by gram-negative bacilli. Med Clin North Am (1967) 0.77

Influence of anesthetic agents on murine pulmonary bactericidal activity. Antimicrob Agents Chemother (Bethesda) (1970) 0.77

Effect of cycloserines on D-amino acid oxidase. Arch Biochem Biophys (1966) 0.77

Treatment of coccidioidomycosis with miconazole. JAMA (1980) 0.76

Tracheobronchial flora in chronic obstructive pulmonary disease: preliminary results with authentic specimens and trial of trimethoprim-sulfamethoxazole. J Infect Dis (1973) 0.76

Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. Eur J Clin Microbiol (1985) 0.76

The changing face of pneumonia. Hosp Pract (1979) 0.76

Bioactive complement fragments in immunoregulation. Immunol Lett (1985) 0.76

Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. Biochemistry (1986) 0.76

Entry of five antifungal agents into the ovine lung. Antimicrob Agents Chemother (1987) 0.76

Effect of vitamin E and ozone on the pulmonary antibacterial defense mechanisms. J Lab Clin Med (1974) 0.76

Illicit intravenous drug use and bacterial endocarditis. Calif Med (1973) 0.75

Totally synthetic medium for susceptibility testing. Antimicrob Agents Chemother (1978) 0.75

Long-term venous access in rhesus monkeys. Antimicrob Agents Chemother (1982) 0.75

Trimethoprim-sulfamethoxazole in chronic bronchitis. Can Med Assoc J (1975) 0.75

Lymphangiography in diagnosis of fever of unknown origin. Calif Med (1973) 0.75